COMMON STOCK PURCHASE WARRANTS (Schedule of activity of warrants) (Details) - Warrant [Member] |
3 Months Ended |
|---|---|
|
Mar. 31, 2018
$ / shares
shares
| |
| Number of Warrants | |
| Outstanding at the beginning of the year | 25,216,332 |
| Warrants expired | |
| Warrants issued | |
| Outstanding at end of period | 25,216,332 |
| Exercisable at end of period | 25,216,332 |
| Weighted Avg. Exercise Price | |
| Outstanding at the beginning of the year | $ / shares | $ 0.65 |
| Outstanding at end of period | $ / shares | 0.65 |
| Exercisable at end of period | $ / shares | $ 0.65 |
| Remaining Contractual Life (Years) | |
| Outstanding at the beginning of the year | 4 years 10 months 25 days |
| Outstanding at end of period | 4 years 7 months 6 days |
| Exercisable at end of period | 4 years 7 months 6 days |
| X | ||||||||||
- Definition Remaining contractual life beginning. No definition available.
|
| X | ||||||||||
- Definition The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|